会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • PHOSPHINIC ACID DERIVATIVES
    • 磷酸衍生物
    • WO1996000732A1
    • 1996-01-11
    • PCT/US1995007128
    • 1995-06-19
    • SCHERING CORPORATION
    • SCHERING CORPORATIONMCKITTRICK, Brian, A.CZARNIECKI, Michael, F.CHACKALAMANNIL, SamuelCHUNG, ShinDEFREES, ShawnSTAMFORD, Andrew, W.
    • C07F09/30
    • C07F9/65583C07F9/303C07F9/5728
    • Phosphinic acid derivatives of structural formula (I) or a pharmaceutically acceptable salt thereof, wherein R is H, alkyl or alkanoyloxymethylene; R1, R2, R3 and R4 are H, alkyl, alkenyl, alkenylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, hydroxyalkyl, carboxyalkyl, thioalkyl, alkoxythioalkyl, aminoalkyl, alkylaminoalkyl, cycloalkyl-substituted alkyl or heterocycloalkyl; or R1 and R2 form a cycloalkyl ring of 3-8 members and R3 and R4 are as defined; or R3 and R4 form a cycloalkyl ring of 3-7 members and R1 and R2 are as defined; or R1 and R2 together, and R3 and R4 together, each form a cycloalkyl ring; R5 is -OR9 or -NHR9, wherein R9 is hydrogen or alkyl; n is 0 or 1; A1 is p-aminobenzoyl or p-aminobenzenesulfonyl, or A1 and R5 together form a radical of an alpha -aminoacyl derivative; and R6 is phenylmethoxycarbonyl, arylcarbonyl, heteroarylcarbonyl or -A2-R7, wherein A2 is a divalent alpha -iminoacyl radical, and R7 is a substituent on the alpha -imino atom selected from H, R8OCO-, R8SO2- and R8NHCO-, wherein R8 is aryl, arylmethyl or (C1-C8)alkyl; are disclosed for use as endothelin converting enzyme inhibitors; also disclosed are a genus of novel compounds wherein R and R form a cycloalkyl ring, and pharmaceutical compositions comprising said novel compounds.
    • 结构式(I)的亚磷酸衍生物或其药学上可接受的盐,其中R是H,烷基或烷酰氧基亚甲基; R 1,R 2,R 3和R 4是H,烷基,烯基,烯基烷基,芳基,芳基烷基,杂芳基,杂芳基烷基,羟基烷基,羧基烷基,硫代烷基,烷氧基硫代烷基,氨基烷基,烷基氨基烷基,环烷基取代的烷基或杂环烷基。 或R 1和R 2形成3-8成员的环烷基环,并且R 3和R 4如所定义; 或R 3和R 4形成3-7成员的环烷基环,并且R 1和R 2如所定义; 或R 1和R 2一起,并且R 3和R 4一起形成环烷基环; R5是-OR9或-NHR9,其中R9是氢或烷基; n为0或1; A1是对氨基苯甲酰基或对氨基苯磺酰基,或者A1和R5一起形成α-氨基酰基衍生物的基团; R6为苯基甲氧基羰基,芳基羰基,杂芳基羰基或-A2-R7,其中A2为二价α-亚氨酰基,R7为选自H,R8OCO-,R8SO2-和R8NHCO-的α-亚氨基原子上的取代基,其中R8 是芳基,芳甲基或(C1-C8)烷基; 被公开用作内皮素转化酶抑制剂; 还公开了其中R 3和R 4形成环烷基环的新化合物的属,以及包含所述新化合物的药物组合物。